End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.81 CNY | +0.94% | +1.03% | -4.99% |
Apr. 18 | Joincare Pharma Says Flu Drug Phase 3 Trial Attains Primary Endpoint | MT |
Apr. 18 | Joincare Pharmaceutical Successfully Completes TG-1000 Phase III Study | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.99% | 3.04B | |
+23.02% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.26% | 219B | |
+6.39% | 199B | |
-10.06% | 196B | |
-8.75% | 149B | |
-5.21% | 146B |
- Stock Market
- Equities
- 600380 Stock
- News Joincare Pharmaceutical Group Industry Co.,Ltd.
- Joincare Pharmaceutical Industry : Sets Up $15 Million Drug Development JV with Livzon Pharma